PubRank

Erika Resetkova

Author PubWeight™ 28.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interpretative problems and preparative technique influence reliability of intraoperative parathyroid touch imprints. Arch Pathol Lab Med 2003 2.02
2 Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer 2007 1.73
3 Primary osteosarcoma of the breast: report of 2 cases. Arch Pathol Lab Med 2007 1.55
4 Imaging features of micropapillary DCIS: correlation with clinical and histopathological findings. Acad Radiol 2011 1.39
5 Pathological examination of sentinel lymph node in breast cancer: potential problems and possible solutions. Microsc Res Tech 2002 1.38
6 Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases. Mod Pathol 2007 1.33
7 Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 2007 1.31
8 Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma. Appl Immunohistochem Mol Morphol 2007 1.29
9 Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med 2009 1.29
10 Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 2006 1.21
11 Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol 2011 1.14
12 Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 2006 1.07
13 Invasive paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast. Am J Surg Pathol 2012 0.94
14 Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer. Ann Surg Oncol 2014 0.93
15 Loss of annexin A1 expression in breast cancer progression. Appl Immunohistochem Mol Morphol 2008 0.89
16 Malignant transformation of adenomyoepithelioma of the breast by a monophasic population: a report of two cases and review of literature. APMIS 2012 0.88
17 Preoperative diagnosis of clear cell "sugar" tumor of the lung by computed tomography-guided fine-needle biopsy and core-needle biopsy. Ann Diagn Pathol 2007 0.86
18 Cytologic features of renal medullary carcinoma. Cancer 2005 0.85
19 Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology 2011 0.83
20 Primary gastrointestinal stromal tumor of the esophagus in an HIV-positive patient. Ann Diagn Pathol 2005 0.82
21 Megakaryocytes mimicking metastatic breast carcinoma. Arch Pathol Lab Med 2002 0.82
22 Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey. Pathol Res Pract 2010 0.81
23 Trastuzumab administration associated with change in HER2 status. Clin Breast Cancer 2008 0.81
24 Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer. Histopathology 2012 0.80
25 A large, fungating breast mass. Secretory carcinoma with apocrine differentiation. Arch Pathol Lab Med 2006 0.79
26 Expression of high-molecular-weight cytokeratin (34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast. J Clin Pathol 2010 0.78
27 Giant cell tumor of soft tissue arising in breast. Ann Diagn Pathol 2007 0.75
28 Is it too soon to start reporting HER2 genetic heterogeneity? Arch Pathol Lab Med 2010 0.75
29 Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow-up. Chin J Cancer 2014 0.75
30 Androgen Receptor (AR) Expression in Invasive Male Breast Carcinoma (MBC): An International Multi-Institutional Review of 168 Cases Emphasizing the Potential Use of AR as a Therapeutic Target. Appl Immunohistochem Mol Morphol 2017 0.75
31 Androgen Receptor (AR) Expression in Invasive Male Breast Carcinoma (MBC): An International Multi-Institutional Review of 168 Cases Emphasizing the Potential Use of AR as a Therapeutic Target. Appl Immunohistochem Mol Morphol 2017 0.75